The group’s principle activities include developing, manufacturing and commercializing bioactive compounds. The group’s technology platforms include TheraPhase(R), ProPhase(TM), CoPhase(TM) and FormEZE(TM). The group’s products include InsuLAR(TM), PulmoLAR(TM), SomaLAR(TM) and Veterinary Alliance. The group operates from United States.